Syntax System Model 200 Instruments- Brand Name or Tender - 105237585

Procurement Summary

Country: USA

Summary: Syntax System Model 200 Instruments- Brand Name or Equal

Deadline: 09 Aug 2024

Posting Date: 04 Aug 2024

Other Information

Notice Type: Tender

TOT Ref.No.: 105237585

Document Ref. No.: NIAID-SS-24-2224327

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Description
Introduction
This is a Sources Sought notice. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding the availability and capability of all qualified sources to perform a potential requirement.
Project Summary
The National Institute of Allergy and Infectious Diseases (NIAID), Vaccine Production Program (VPP) is seeking a Syntax System Model 200 (Brand Name or Equal) to provide on-demand synthesis of oligonucleotides. The instrument oligo bioprinter requested can produce 96 x 120 nucleotide base oligos. These oligos will create a gene that encodes a vaccine or a biotherapeutic candidate.
Specifically, NIAID, VRC is seeking a Syntax System Model 200 that can perform the following applications:
Need for one (1) High-throughput Syntax System Model 200. This instrument should include the following:
Fully automated enzymatic DNA synthesis system that goes from the 5 prime to 3 prime direction which is done in a template independent manner where the final oligos produced will include a native phosphate group at the 5 prime end. Oligonucleotide are synthesized, quantified, and normalized in a single synthesis run without user interaction. Need the ability to produce both a labeled and unlabeled Oligonucleotide, 96 or 384 simultaneously. Must be able to produce a minimum of 90 oligos of 120 nucleotides in length within a 24 hour period. Oligonucleotide produced must have a low sequence error rate (below 10% for 120 nucleotides Oligonucleotide). Ability to incorporate a specific sequence to each of the 96 oligos being synthesized. Must be a fully automated system that after set up does not need to be attended by lab personnel Produced Oligonucleotide must be ready for downstream application. System must have no specialized facility requirements and no hazardous chemicals or organic solvents used in the production of the Oligonucleotide. Design and contr...
Active Contract Opportunity Notice ID NIAID-SS-24-2224327 Related Notice Department/Ind. Agency HEALTH AND HUMAN SERVICES, DEPARTMENT OF Sub-tier NATIONAL INSTITUTES OF HEALTH Office NATIONAL INSTITUTES OF HEALTH NIAID

General Information

Contract Opportunity Type: Sources Sought (Original)

All Dates/Times are: (UTC-04:00) EASTERN STANDARD TIME, NEW YORK, USA

Original Published Date: Aug 02, 2024 01:12 pm EDT

Original Response Date: Aug 09, 2024 03:00 pm EDT

Inactive Policy: 15 days after response date

Original Inactive Date: Aug 24, 2024

Initiative: None
Classification

Original Set Aside:

Product Service Code: 6640 - LABORATORY EQUIPMENT AND SUPPLIES

NAICS Code: 334516 - Analytical Laboratory Instrument Manufacturing
Place of Performance: Gaithersburg, MD 20878 USA

Documents

 Tender Notice